Although CDKN2A was preferentially expressed in Calu3 and H1299 cells (Fig. 3c), p16 is dysfunctional in all four NSCLC cell lines used in the current study because of mutations in CDKN2A9. This evidence concerns the gene CDKN2A and non-small cell lung carcinoma.